Sign in

CIK 0001069899

  • Large accelerated filer

PHIBRO ANIMAL HEALTH CORP

Sign in to watch
Ticker
PAHC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
131840497
Phone
+1 201-329-7300
Business address
GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
Former names
PHILIPP BROTHERS CHEMICALS INC
  1. 4 Grant or award Exec. VP, Corporate Strategy acquired 3,964 shares (grant or award)
  2. 4 Grant or award President and CEO acquired 16,840 shares (grant or award)
  3. 4 Grant or award Escudero Lisa Ann acquired 2,152 shares (grant or award)
  4. 4 Grant or award Andolino Anthony acquired 1,793 shares (grant or award)
  5. 4 Open-market buy Director bought 5,000 shares at $22.10 ($110,500)
  6. 4 Exercise or conversion Chief Financial Officer acquired 30,000 shares (option exercise)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy Director bought 5,000 shares at $20.02 ($100,100)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy Director bought 5,000 shares at $23.68 ($118,400)
  15. 4 Open-market sale Chief Operating Officer sold 20,000 shares at $22.94 ($458,812)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy Director bought 5,000 shares at $21.21 ($106,050)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale Exec. VP, Corporate Strategy sold 9,780 shares at an average $31.34 ($306,478)
  20. 4 Open-market sale Exec. VP, Corporate Strategy sold 7,500 shares at an average $31.63 ($237,254)

Page 4 of 17 · 334 filings